Pharmaceutical

AI Healthcare Funding Surges as Real-World Rollouts Hit Pharmacies, Hospitals, and Providers

Equity Insider News CommentaryIssued on behalf of Avant Technologies Inc. VANCOUVER, BC, June 17, 2025 /PRNewswire/ -- Venture Capital continues to…

6 months ago

Genomenon Powers Groundbreaking Study on Genetic Drivers of Rare Liver Disorders

ANN ARBOR, Mich., June 17, 2025 /PRNewswire/ -- Genomenon, a leading genomic intelligence company, today announced its pivotal role in…

6 months ago

Waters Enhances Alliance iS HPLC System Software, Setting a New Standard for End-to-End Traceability and Data Integrity

News Summary Industry-first smart HPLC system to provide authenticated user access verification on onboard touchscreen for superior security. Integration of…

6 months ago

One2Treat, the leading company incorporating the patient voice into clinical development, launches One2Treat Voice app

LOUVAIN-LA-NEUVE, Belgium, June 17, 2025 /PRNewswire/ -- One2Treat SA, a fast-growing tech company incorporating the patient voice in all strategic decisions…

6 months ago

Ratio Therapeutics and Nusano Enter Long-Term, Multi-Isotope Supply Agreement to Boost Production of Cancer Radiopharmaceuticals

Agreement provides Ratio access to Nusano-produced radioisotopes for oncology diagnostics and therapeuticsAccelerates Ratio's clinical pipeline with copper-64 for PET imaging and…

6 months ago

Lifecore Biomedical Signs New 10-Year Commercial Manufacturing and Supply Agreement with Key Existing Customer

Represents Continuation of Long-Running Partnership Focused on Supporting Advancement of Novel Ophthalmic Therapeutic Toward CommercializationCHASKA, Minn., June 17, 2025 (GLOBE…

6 months ago

Eccogene to Report Preclinical Data with ECC4703, Showcasing Impact on Lean Muscle Sparing and Fat Loss in Combination with Semaglutide and Tirzepatide

Late-breaking poster presentation to be reviewed at the upcoming American Diabetes Association’s 85th Scientific SessionsBOSTON and SHANGHAI, June 17, 2025…

6 months ago

Kamada Confirms Continuous Global Business Operations and Products Availability Despite Recent Events in the Middle East

REHOVOT, Israel and HOBOKEN, N.J., June 17, 2025 (GLOBE NEWSWIRE) -- Kamada Ltd. (NASDAQ: KMDA; TASE: KMDA.TA), a global biopharmaceutical…

6 months ago

Ventyx Biosciences Announces Positive Top-Line Data from its Phase 2a Safety and Biomarker Trial Evaluating VTX3232 in Patients with Early-Stage Parkinson’s Disease

The study met its primary goal of establishing safety and tolerability of VTX3232 in patients with early-stage Parkinson’s disease CSF…

6 months ago